{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T16:23:42Z","timestamp":1790267022072,"version":"4.1.0"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejradiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Radiology"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.ejrad.2021.110095","type":"journal-article","created":{"date-parts":[[2021,12,4]],"date-time":"2021-12-04T10:29:25Z","timestamp":1638613765000},"page":"110095","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"special_numbering":"C","title":["Radiomics features based on automatic segmented MRI images: Prognostic biomarkers for triple-negative breast cancer treated with neoadjuvant chemotherapy"],"prefix":"10.1016","volume":"146","author":[{"given":"Mingming","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liangyu","family":"Gan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinhua","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Xin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naishan","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanjia","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaofeng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangpeng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingming","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"20","key":"10.1016\/j.ejrad.2021.110095_b0005","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1056\/NEJMra1001389","article-title":"Triple-negative breast cancer","volume":"363","author":"Foulkes","year":"2010","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.ejrad.2021.110095_b0010","first-page":"619","article-title":"Differences in breast cancer survival by molecular subtypes in the United States, cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive","volume":"27","author":"Howlader","year":"2018","journal-title":"Oncology"},{"issue":"8","key":"10.1016\/j.ejrad.2021.110095_b0015","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1200\/JCO.2007.14.4147","article-title":"Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer","volume":"26","author":"Liedtke","year":"2008","journal-title":"J. Clin. Oncology: Official J. Am. Soc. Clin. Oncol."},{"key":"10.1016\/j.ejrad.2021.110095_b0020","doi-asserted-by":"crossref","unstructured":"M. Golshan, C.T. Cirrincione, W.M. Sikov, D.A. Berry, S. Jasinski, T.F. Weisberg, G. Somlo, C. Hudis, E. Winer, D.W. Ollila, Impact of neoadjuvant chemotherapy in stage II-III triple negative breast cancer on eligibility for breast-conserving surgery and breast conservation rates: surgical results from CALGB 40603 (Alliance), Ann. Surg. 262 (3) (2015) 434\u2013439, discussion 438\u2013439.","DOI":"10.1097\/SLA.0000000000001417"},{"issue":"1","key":"10.1016\/j.ejrad.2021.110095_b0025","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s10549-019-05290-0","article-title":"Patterns of relapse after neoadjuvant chemotherapy in breast cancer: implications for surveillance in clinical practice","volume":"177","author":"Saw","year":"2019","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.ejrad.2021.110095_b0030","doi-asserted-by":"crossref","first-page":"10603","DOI":"10.2147\/CMAR.S271876","article-title":"MRI-based radiomic signature as a prognostic biomarker for HER2-positive invasive breast cancer treated with NAC","volume":"12","author":"Li","year":"2020","journal-title":"Cancer Manage. Res."},{"issue":"1","key":"10.1016\/j.ejrad.2021.110095_b0035","doi-asserted-by":"crossref","first-page":"2976","DOI":"10.1038\/s41598-020-59923-2","article-title":"Three-dimensional radiomics of triple-negative breast cancer: prediction of systemic recurrence","volume":"10","author":"Koh","year":"2020","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.ejrad.2021.110095_b0040","doi-asserted-by":"crossref","first-page":"3750","DOI":"10.1038\/s41598-020-60822-9","article-title":"MRI radiomic features: association with disease-free survival in patients with triple-negative breast cancer","volume":"10","author":"Kim","year":"2020","journal-title":"Sci. Rep."},{"issue":"12","key":"10.1016\/j.ejrad.2021.110095_b0045","doi-asserted-by":"crossref","first-page":"e2028086","DOI":"10.1001\/jamanetworkopen.2020.28086","article-title":"Development and validation of a preoperative magnetic resonance imaging radiomics-based signature to predict axillary lymph node metastasis and disease-free survival in patients with early-stage breast cancer","volume":"3","author":"Yu","year":"2020","journal-title":"JAMA Network Open"},{"issue":"6","key":"10.1016\/j.ejrad.2021.110095_b0050","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1002\/jmri.27565","article-title":"Radiomics models based on apparent diffusion coefficient maps for the prediction of high-grade prostate cancer at radical prostatectomy: comparison with preoperative biopsy","volume":"54","author":"Han","year":"2021","journal-title":"J. Magn. Reson. Imaging: JMRI"},{"key":"10.1016\/j.ejrad.2021.110095_b0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejrad.2021.109693","article-title":"Preoperative prediction of clinically relevant postoperative pancreatic fistula after pancreaticoduodenectomy","volume":"139","author":"Lin","year":"2021","journal-title":"Eur. J. Radiol."},{"issue":"08","key":"10.1016\/j.ejrad.2021.110095_b0060","first-page":"1025","article-title":"Automatic breast cancer segmentation and location on DCE-MRI using U-Net convolution neural network: a preliminary study","volume":"35","author":"Ma","year":"2020","journal-title":"Radiol. Practice"},{"issue":"8","key":"10.1016\/j.ejrad.2021.110095_b0065","doi-asserted-by":"crossref","first-page":"e0237587","DOI":"10.1371\/journal.pone.0237587","article-title":"FeAture Explorer (FAE): A tool for developing and comparing radiomics models","volume":"15","author":"Song","year":"2020","journal-title":"PLoS ONE"},{"issue":"2","key":"10.1016\/j.ejrad.2021.110095_b0070","doi-asserted-by":"crossref","first-page":"R22","DOI":"10.1186\/bcr2834","article-title":"Ki-67 can be used for further classification of triple negative breast cancer into two subtypes with different response and prognosis","volume":"13","author":"Keam","year":"2011","journal-title":"Breast Cancer Res.: BCR"},{"issue":"1","key":"10.1016\/j.ejrad.2021.110095_b0075","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s12885-017-3969-y","article-title":"Clinical and pathological factors influencing survival in a large cohort of triple-negative breast cancer patients","volume":"18","author":"Urru","year":"2018","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.ejrad.2021.110095_b0080","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1158\/1078-0432.CCR-14-3304","article-title":"Relationship between complete pathologic response to neoadjuvant chemotherapy and survival in triple-negative breast cancer","volume":"22","author":"Hatzis","year":"2016","journal-title":"Clin. Cancer Res."},{"issue":"19","key":"10.1016\/j.ejrad.2021.110095_b0085","doi-asserted-by":"crossref","first-page":"4705","DOI":"10.1158\/1078-0432.CCR-17-3783","article-title":"Radiomics signature on magnetic resonance imaging: association with disease-free survival in patients with invasive breast cancer","volume":"24","author":"Park","year":"2018","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ejrad.2021.110095_b0090","doi-asserted-by":"crossref","unstructured":"D.M. Ye, H.T. Wang, T. Yu, The application of radiomics in breast MRI: a review, Technol. Cancer Res. Treat. 19 (2020) 1533033820916191.","DOI":"10.1177\/1533033820916191"},{"issue":"22","key":"10.1016\/j.ejrad.2021.110095_b9000","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1056\/NEJMoa1612645","article-title":"Adjuvant capecitabine for breast cancer after preoperative chemotherapy","volume":"376","author":"Masuda","year":"2017","journal-title":"New England J. Med."},{"issue":"12","key":"10.1016\/j.ejrad.2021.110095_b9005","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1200\/JCO.2009.23.8303","article-title":"Capecitabine in addition to anthracycline- and taxane-based neoadjuvant treatment in patients with primary breast cancer: phase III GeparQuattro study","volume":"28","author":"von Minckwitz","year":"2010","journal-title":"J. Clin. Oncol. : Official J. Am. Soc. Clin. Oncol."},{"issue":"32","key":"10.1016\/j.ejrad.2021.110095_b9010","doi-asserted-by":"crossref","first-page":"3788","DOI":"10.1200\/JCO.2015.61.9510","article-title":"Epirubicin plus cyclophosphamide followed by docetaxel versus epirubicin plus docetaxel followed by capecitabine as adjuvant therapy for node-positive early breast cancer: results from the GEICAM\/2003-10 study","volume":"33","author":"Mart\u00edn","year":"2015","journal-title":"J. Clin. Oncol. : Official J. Am. Soc. Clin. Oncol."}],"container-title":["European Journal of Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0720048X21005763?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0720048X21005763?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T07:29:51Z","timestamp":1759994991000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0720048X21005763"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":21,"alternative-id":["S0720048X21005763"],"URL":"https:\/\/doi.org\/10.1016\/j.ejrad.2021.110095","relation":{},"ISSN":["0720-048X"],"issn-type":[{"value":"0720-048X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Radiomics features based on automatic segmented MRI images: Prognostic biomarkers for triple-negative breast cancer treated with neoadjuvant chemotherapy","name":"articletitle","label":"Article Title"},{"value":"European Journal of Radiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejrad.2021.110095","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"110095"}}